Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus zinc supplementation for opioid dependence and male fertility
IRCT20221022056266N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin and zinc in opioid use disorder (OUD) and male infertility, sponsored by Zanjan University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
oxytocinzinc
03
Conditions
opioid use disorder (OUD)male infertility
Beyond the preview
Go deeper on IRCT20221022056266N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221022056266N1.